Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct;114(4):836-844.
doi: 10.1002/cpt.2981. Epub 2023 Jul 11.

Patterns of Prescription Medication Use during the First Trimester of Pregnancy in the United States, 1997-2018

Affiliations

Patterns of Prescription Medication Use during the First Trimester of Pregnancy in the United States, 1997-2018

Martha M Werler et al. Clin Pharmacol Ther. 2023 Oct.

Abstract

The objective of this analysis was to describe patterns of prescription medication use during pregnancy, including secular trends, with consideration of indication, and distributions of use within demographic subgroups. We conducted a descriptive secondary analysis using data from 9,755 women whose infants served as controls in two large United States case-control studies from 1997-2011 and 2014-2018. After excluding vitamin, herbal, mineral, vaccine, i.v. fluid, and topical products and over-the-counter medications, the proportion of women that reported taking at least one prescription medication in the first trimester increased over the study years, from 37% to 50% of women. The corresponding proportions increased with increasing maternal age and years of education, were highest for non-Hispanic White women (47%) and lowest for Hispanic women (24%). The most common indication for first trimester use of a medication was infection (12-15%). Increases were observed across the years for medications used for indications related to nausea/vomiting, depression/anxiety, infertility, thyroid disease, diabetes, and epilepsy. The largest relative increase in use among women was observed for medications to treat nausea/vomiting, which increased from 3.8% in the earliest years of the study (1997-2001) to 14.8% in 2014-2018, driven in large part by ondansetron use. Prescription medication use in the first trimester of pregnancy is common and increasing. Many medical conditions require treatments among pregnant women, often involving pharmacotherapy, which necessitates consideration of the risk and safety profiles for both mother and fetus.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

Dr. Mitchell is a member of the Pregnancy Advisory Board for Biogen’s Tecfidera Pregnancy Registry. Dr. Werler serves as a diagnostic adjudicator for Novartis pregnancy registries. All other authors declared no competing interests for this work.

Figures

Figure 1
Figure 1
Prescription medication use in first trimester*, National Birth Defects Prevention Study (1997–2011) and Birth Defects Study to Evaluate Pregnancy Exposures (2014–2018). (a) Percent taking >1 medication (error bars indicate 95% confidence intervals). (b) Average number of prescription medications taken (error bars indicate 95% confidence intervals). *First trimester, 30 days before to 90 days after pregnancy onset.
Figure 2
Figure 2
Prescription medication use in first trimester* over time, National Birth Defects Prevention Study (1997–2011) and Birth Defects Study to Evaluate Pregnancy Exposures (2014–2018). (a) Anti-infective medication use. (b) Anti-nausea/vomiting medication use. (c) Antidepressant/anxiety medication use. (d) Fertility medication use. (e) Thyroid and anti-diabetic medication. * All reported use, including non-thyroid indications. ** All reported use, including non-diabetic medications. (f) Anti-convulsant medication use, including non-seizure indications. (g) Opioid medication use. *First trimester, 30 days before to 90 days after pregnancy onset. (Error bars represent 95% confidence intervals.)

Similar articles

Cited by

References

    1. Feghali M, Venkataramanan R & Caritis S Pharmacokinetics of drugs in pregnancy. Semin. Perinatol 39, 512–519 (2015). - PMC - PubMed
    1. Lenz W A short history of thalidomide embryopathy. Teratology 38, 203–215 (1988). - PubMed
    1. Mitchell AA, Gilboa SM, Werler MM, Kelley KE, Louik C & Hernández-Díaz S Medication use during pregnancy, with particular focus on prescription drugs: 1976–2008. Am. J. Obstet. Gynecol 205, 51.e1–51.e8 (2011). - PMC - PubMed
    1. Reefhuis J et al. The national birth defects prevention study: a review of the methods. Birth Defects Res. Part A – Clin. Mol. Teratol 103, 656–669 (2015). - PMC - PubMed
    1. Tinker SC et al. Next steps for birth defects research and prevention: the birth defects study to evaluate pregnancy exposureS (BD-STEPS). Birth Defects Res. A Clin. Mol. Teratol 103, 733–740 (2015). - PMC - PubMed

Publication types

Substances

LinkOut - more resources